FDA Inspection 1329094 — Bushu Pharmaceuticals Ltd.

Bushu Pharmaceuticals Ltd. — FEI 3005709762

The FDA completed an inspection of Bushu Pharmaceuticals Ltd. on Aug 3, 2026 in Kawagoe. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 2 citations were issued during this inspection. Product area: Veterinary.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Aug 3, 2026
Fiscal Year
2026
Product Type
Veterinary
Project Area
Monitoring of Marketed Animal Drugs, Feed, and Devices
Location
Kawagoe (Japan)

Citations

IDCFRDescription
203121 CFR 211.194(a)Complete test data included in records
358321 CFR 211.110(a)Written in-process control procedures

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.